Careers  |  Sign In  |  Register

New Drug Shown to Lower LDL Cholesterol

According to Reuters, Repatha is a new drug developed by Amgen that helps to lower cholesterol without seeming to have serious adverse side effects. The next step in the process is on Wednesday, when outside advisors to the FDA will recommend whether they believe the drug should be approved or not. Repatha’s mechanism of action is part of a newer class of drugs known as PCSK9 inhibitors, which specifically lower LDL cholesterol. Although Repatha is not the only drug in its class, Amgen is hopeful that with low risk side effects, the FDA advisory panel will recommend its drug for approval.


Read the article published on Reuters.